Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A nasal glucagon-like peptide-1 compound could be used to effectively treat type 2 diabetes, but future trials are still needed, according to findings from a Japanese study published in Diabetes Care.
In a prospective, randomized, double blind study, Hiroaki Ueno, MD, of the University of Miyazaki, and colleagues divided 26 patients with type 2 diabetes into groups to receive an intranasal powder formulation of GLP-1 (n=18) or placebo (n=8). Participants, aged 20 to 70 years, had inadequately controlled conditions through oral antidiabetic drugs. Age, sex, BMI and HbA1c levels did not differ significantly between groups.
http://www.healio.com/endocrinology...p-1-compound-shows-promise-in-type-2-diabetes
Sciencey-types, I've often wondered what 'prospective' means in this context - can anyone enlighten me? 🙂
In a prospective, randomized, double blind study, Hiroaki Ueno, MD, of the University of Miyazaki, and colleagues divided 26 patients with type 2 diabetes into groups to receive an intranasal powder formulation of GLP-1 (n=18) or placebo (n=8). Participants, aged 20 to 70 years, had inadequately controlled conditions through oral antidiabetic drugs. Age, sex, BMI and HbA1c levels did not differ significantly between groups.
http://www.healio.com/endocrinology...p-1-compound-shows-promise-in-type-2-diabetes
Sciencey-types, I've often wondered what 'prospective' means in this context - can anyone enlighten me? 🙂